Following a broad domestic and international search, with the assistance of our Clairfield partners, DZG Investments, the Australian subsidiary of the Goubuli Group, a Chinese food and beverage company, has acquired an 80% stake in BJP Laboratories, a leading Australian contract manufacturer of listed medicines. InterFinancial assumed a lead advisory role on the transaction […]
Read more
Clairfield International has further expanded its global M&A presence through a new partnership in the United States with Atlanta-based investment bank Croft & Bender. Croft & Bender provides mergers and acquisitions, private capital-raising, and financial advisory services to middle-market and emerging growth companies. Croft & Bender will be exclusive partner for Clairfield in the United […]
Read more
Charm Health is Australia’s leading supplier of specialist medical oncology e-health systems, with its solutions used by leading public and private health providers of cancer care. OneVentures first invested in Charm Health in 2013 through OneVentures Innovation Fund I and has been instrumental in supporting the Charm Health team in increasing market share and reinforcing […]
Read more
